Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens.
作者信息
Ham Rachel E, Temesvari Lesly A
机构信息
Department of Biological Sciences, Clemson University, Clemson, South Carolina, Unites States of America.
Eukaryotic Pathogens Innovation Center (EPIC), Clemson University, Clemson, South Carolina, Unites States of America.
出版信息
PLoS Pathog. 2020 Dec 31;16(12):e1009081. doi: 10.1371/journal.ppat.1009081. eCollection 2020 Dec.
Abstract
摘要
相似文献
1
Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens.
PLoS Pathog. 2020 Dec 31;16(12):e1009081. doi: 10.1371/journal.ppat.1009081. eCollection 2020 Dec.
2
Key aspects of antimicrobial stewardship.
J Hosp Med. 2012;7 Suppl 1:S1. doi: 10.1002/jhm.989.
3
Key aspects of antimicrobial stewardship.
J Hosp Med. 2012;7 Suppl 1:S1. doi: 10.1002/jhm.989.
4
The antimicrobial action of potential thiol reagents.
Zentralbl Bakteriol Orig. 1970;14(4):507-17.
5
Introduction: Drug Resistance.
Chem Rev. 2021 Mar 24;121(6):3235-3237. doi: 10.1021/acs.chemrev.1c00118.
6
Using combination therapy to thwart drug resistance.
Future Microbiol. 2015;10(11):1719-26. doi: 10.2217/fmb.15.68.
7
Focus on drug resistance.
Trends Microbiol. 1999 Sep;7(9):344-5. doi: 10.1016/s0966-842x(99)01573-5.
8
A comprehensive review of the antibacterial, antifungal and antiviral potential of essential oils and their chemical constituents against drug-resistant microbial pathogens.
Microb Pathog. 2019 Sep;134:103580. doi: 10.1016/j.micpath.2019.103580. Epub 2019 Jun 11.
9
The essential features of microorganisms and the rationale for antimicrobial therapy.
Br Dent J. 1992 May 9;172(9):339-43. doi: 10.1038/sj.bdj.4807875.
10
Antifungal activity of nonantifungal drugs.
Eur J Clin Microbiol Infect Dis. 2003 Jul;22(7):397-407. doi: 10.1007/s10096-003-0947-x. Epub 2003 Jun 26.
本文引用的文献
1
In vitro effectivity of three approved drugs and their synergistic interaction against Leishmania infantum.
Biomedica. 2020 May 1;40(Supl. 1):89-101. doi: 10.7705/biomedica.4891.
2
Activity of Auranofin against Multiple Genotypes of and Its Synergistic Effect with Amphotericin B .
ACS Chem Neurosci. 2020 Aug 19;11(16):2464-2471. doi: 10.1021/acschemneuro.0c00165. Epub 2020 May 26.
3
Microalgae extracts: Potential anti-Trypanosoma cruzi agents?
Biomed Pharmacother. 2020 Jul;127:110178. doi: 10.1016/j.biopha.2020.110178. Epub 2020 May 3.
4
In vitro and in vivo antitrypanosomal efficacy of combination therapy of Anogeissus leiocarpus, Khaya senegalensis and potash.
J Ethnopharmacol. 2020 Aug 10;258:112805. doi: 10.1016/j.jep.2020.112805. Epub 2020 Mar 31.
5
Aspiring Antifungals: Review of Current Antifungal Pipeline Developments.
J Fungi (Basel). 2020 Feb 25;6(1):28. doi: 10.3390/jof6010028.
6
Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria.
PLoS One. 2020 Feb 13;15(2):e0228996. doi: 10.1371/journal.pone.0228996. eCollection 2020.
7
Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069.
PLoS Negl Trop Dis. 2020 Jan 21;14(1):e0007481. doi: 10.1371/journal.pntd.0007481. eCollection 2020 Jan.
8
Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against In Vitro.
Pathogens. 2020 Jan 9;9(1):49. doi: 10.3390/pathogens9010049.
9
Evaluation of the Antifungal Activity of (Lamiaceae) of Pancalieri (Turin, Italy) Essential Oil and Its Synergistic Interaction with Azoles.
Molecules. 2019 Aug 29;24(17):3148. doi: 10.3390/molecules24173148.
10
Miltefosine-Lopinavir Combination Therapy Against Infection: and Approaches.
Front Cell Infect Microbiol. 2019 Jun 28;9:229. doi: 10.3389/fcimb.2019.00229. eCollection 2019.
Zotero 插件